49.94 USD
▲+2.13+1.38%
盘后 49.26 0.00%
2026-08-03
市值
$2.25B
市盈率
—
EPS
-1.92
股息率
—
52 周区间
16.48 – 51.57
成交量
913.01K
Beta
—
目标价
51.60
52W 低 16.4852W 高 51.57
价格走势
公司简介
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1...